Related Experiment Videos
Cytokine expression in colon carcinoma.
Peter K Baier1, Guido Wolff-Vorbeck, Stephan Eggstein
1University of Freiburg, Department of Surgery, Freiburg, Germany. baier@chir.ukl.uni-freiburg.de
Anticancer Research
|September 15, 2005
Summary
Colon cancer exhibits elevated levels of inflammatory cytokines (IL-1alpha, IL-4, IL-5, TNF-alpha) and reduced IL-2, indicating immune suppression. This suggests Th2 cell activation and potential immune escape mechanisms within the tumor microenvironment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cytokines are key indicators of immune system activity.
- Colon cancer involves complex immune responses within the tumor microenvironment.
- Understanding local cytokine expression is crucial for characterizing immune cell activity in cancer.
Purpose of the Study:
- To analyze the local expression of cytokines in colon cancer tissue.
- To determine the levels of cytokines associated with unspecific inflammation, Th1-cells, and Th2-cells.
- To investigate the relationship between cytokine profiles and immune responses in colon tumors.
Main Methods:
- Quantification of cytokines (IL-1alpha, IL-2, IL-4, IL-5, IL-15, TNF-alpha, IFN-gamma) using real-time PCR.
- Analysis of 25 paired tumor and adjacent normal mucosa samples from colon cancer patients.
- Comparative analysis of cytokine expression between tumor and non-tumor tissues.
Main Results:
- Significant upregulation of IL-1alpha, IL-4, IL-5, and TNF-alpha in colon tumor tissue compared to normal mucosa.
- Significant downregulation of IL-2 in tumor tissue relative to normal mucosa.
- Differential expression patterns observed for various cytokines indicate distinct immune cell activities.
Conclusions:
- The cytokine profile in colon cancer suggests a pronounced unspecific inflammatory response, evidenced by high IL-1 and TNF-alpha levels.
- A low level of IL-2 indicates suppression of specific Th1-cell mediated immunity, potentially contributing to immune escape.
- The findings suggest concurrent activation of Th2 cells in colon carcinomas, highlighting a complex immune landscape.